Farallon Capital Management LLC Jazz Pharmaceuticals PLC Transaction History

Farallon Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$133.98 - $160.47 $10.7 Million - $12.8 Million	-79,800 Reduced 34.73%	150,000 $21.9 Million
Q4 2022 Feb 14, 2023	SELL	$129.72 - $159.85 $39.9 Million - $49.2 Million	-307,700 Reduced 57.25%	229,800 $36.6 Million
Q3 2022 Nov 14, 2022	SELL	$126.59 - $161.18 $48.4 Million - $61.7 Million	-382,600 Reduced 41.58%	537,500 $71.6 Million
Q2 2022 Aug 15, 2022	BUY	$141.59 - $168.66 $83.7 Million - $99.7 Million	591,100 Added 179.67%	920,100 $144 Million
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $13.2 Million - $16.4 Million	-102,021 Reduced 23.67%	329,000 $51.2 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $17.2 Million - $21 Million	-143,886 Reduced 25.03%	431,021 $54.9 Million
Q3 2021 Nov 15, 2021	BUY	$128.64 - $184.79 $74 Million - $106 Million	574,907 New	574,907 $74.9 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.